Moss Genomics Inc. (MOSS.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 55 | 12 | 18 | 688 |
| Receivables | 25 | 20 | 16 | 2 |
| Other current assets | 1,076 | 0 | 0 | 0 |
| TOTAL | $1,175 | $32 | $60 | $689 |
| Non-Current Assets | ||||
| PPE Net | 21 | 41 | 61 | 81 |
| Intangibles | 0 | 0 | 6 | 31 |
| TOTAL | $21 | $41 | $67 | $112 |
| Total Assets | $1,196 | $73 | $127 | $802 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 5 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 124 | N/A | N/A | N/A |
| Accrued Expenses | 30 | N/A | N/A | N/A |
| TOTAL | $259 | $99 | $50 | $140 |
| Non-Current Liabilities | ||||
| Deferred Revenues | 100 | N/A | N/A | N/A |
| TOTAL | $0 | $0 | $0 | $0 |
| Total Liabilities | $259 | $99 | $50 | $140 |
| Shareholders' Equity | ||||
| Common Shares | 2,972 | 1,483 | 1,453 | 1,408 |
| Retained earnings | -2,286 | -1,610 | -1,477 | -747 |
| Other shareholders' equity | 251 | 100 | 100 | 0 |
| TOTAL | $937 | $-27 | $76 | $661 |
| Total Liabilities And Equity | $1,196 | $73 | $127 | $802 |